Bausch + Lomb Execs to Discuss Strategy at Goldman Sachs Healthcare Conference
Event summary
- Bausch + Lomb Chairman and CEO Brent Saunders and Chief Medical Officer Yehia Hashad, MD, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026.
- The session is scheduled for 1:20 p.m. ET and will be available via live webcast on Bausch + Lomb's Investor Relations page.
- Bausch + Lomb is a global eye health company with a portfolio spanning contact lenses, prescription products, OTC options, and surgical devices.
The big picture
Bausch + Lomb's participation in the Goldman Sachs conference underscores its efforts to engage with investors and analysts during a period of heightened focus on healthcare innovation. The company's broad product portfolio positions it well in the eye health market, but it must navigate competitive pressures and demonstrate sustained innovation to maintain its growth trajectory.
What we're watching
- Strategic Vision
- How Bausch + Lomb's leadership will articulate its long-term growth strategy amid increasing competition in the eye health sector.
- R&D Focus
- Whether the company's emphasis on innovation will translate into near-term product breakthroughs or pipeline advancements.
- Market Positioning
- The pace at which Bausch + Lomb can differentiate itself in a crowded market dominated by larger players.
Related topics